Among other things, there can be no guarantee that future study results will be consistent with the results to date, that Zepbound will receive additional regulatory approvals, that Zepbound will be commercially successful, or that Lilly will execute its strategy as planned
In a seminal March 2021 New England Journal of Medicine study, adults receiving a weekly 2.4 mg injection of semaglutide for about 15 months lost 15% of their body weight35 pounds, on averagecompared to just 2.4% body weight loss in the placebo group
Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, et al
other investigations have shown that LFC reduction associated with metabolic disorder improvement and a relative decrease of 30% combined with an improvement in ALT may be predictive of a more active histological response
Find articles by Wise, J
Published online December 20, 2005 Muscle Nerve 1991